Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zealand Pharma A/S ADR (NQ: ZEAL ) N/A UNCHANGED Last Price Updated: 3:24 PM EDT, Sep 29, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 8.820 (2) Ask (Size) 20.00 (2) Prev. Close 17.59 Today's Range N/A - N/A 52wk Range N/A - N/A Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022 November 03, 2022 From Zealand Pharma Via GlobeNewswire Zealand Pharma Announces Presentations at The Obesity Society Annual Meeting November 01, 2022 From Zealand Pharma Via GlobeNewswire Performance More News Read More Zealand Pharma major shareholder announcement: Polar Capital October 11, 2022 From Zealand Pharma Via GlobeNewswire Zealand Pharma major shareholder announcement: Van Herk Investments October 10, 2022 From Zealand Pharma Via GlobeNewswire Zealand Pharma's Dasiglucagon Aces Late-Stage Study In Pediatric Patients, Shares Move Higher May 19, 2022 Via Benzinga Recap: Zealand Pharma Q1 Earnings May 12, 2022 Via Benzinga Zealand Pharma completes registration of capital increase October 07, 2022 From Zealand Pharma Via GlobeNewswire Zealand Pharma announces completion of a directed issue and private placement of 4,975,000 new ordinary shares raising gross proceeds of approx. DKK 786 million October 04, 2022 From Zealand Pharma Via GlobeNewswire Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares October 04, 2022 From Zealand Pharma Via GlobeNewswire Novo Nordisk Touts Another Once-Weekly Insulin Icodec Win In Type 2 Diabetes October 03, 2022 Via Benzinga Total number of shares and voting rights in Zealand Pharma at September 30, 2022 September 30, 2022 From Zealand Pharma Via GlobeNewswire Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1) September 30, 2022 From Zealand Pharma Via GlobeNewswire Zealand Pharma, Novo Nordisk Ink Licensing Pact For Drug To Lower Blood Sugar Levels September 07, 2022 Via Benzinga Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful August 09, 2022 Via Benzinga Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday August 15, 2022 Via Benzinga Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session August 12, 2022 Via Benzinga The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial June 21, 2022 Via Benzinga 71 Biggest Movers From Yesterday May 20, 2022 Via Benzinga Mid-Afternoon Market Update: Dow Falls 150 Points; NeuroMetrix Shares Spike Higher May 19, 2022 Via Benzinga 38 Stocks Moving In Thursday's Mid-Day Session May 19, 2022 Via Benzinga Why Zealand Pharma Shares Are Rising May 19, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 19, 2022 Via Benzinga The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation May 17, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Monday May 16, 2022 Via Benzinga The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More May 12, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.